Showing 3,121 - 3,140 results of 14,966 for search '(( significant ((i.e decrease) OR (we decrease)) ) OR ( significantly increased decrease ))', query time: 0.70s Refine Results
  1. 3121

    ESI-HRMS spectra for Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    “…This unique design enables both THR-β activation and targeted delivery to hepatocytes, which significantly reduces the risk of adverse effects related to increased systemic thyroid hormone activity. …”
  2. 3122

    Experimental Investigation of the Impact of Mixed Wettability on Pore-Scale Fluid Displacement: A Microfluidic Study by Abdullah AlOmier (20402765)

    Published 2024
    “…Results indicated that both the injection time and dynamic pressure decreased with an increase in the hydrophilic area fraction. …”
  3. 3123

    Experimental Investigation of the Impact of Mixed Wettability on Pore-Scale Fluid Displacement: A Microfluidic Study by Abdullah AlOmier (20402765)

    Published 2024
    “…Results indicated that both the injection time and dynamic pressure decreased with an increase in the hydrophilic area fraction. …”
  4. 3124
  5. 3125
  6. 3126
  7. 3127
  8. 3128
  9. 3129
  10. 3130
  11. 3131
  12. 3132
  13. 3133
  14. 3134
  15. 3135
  16. 3136
  17. 3137
  18. 3138

    5-HT inhibits <i>P</i>. <i>berghei</i> infection in mosquitoes. by Li Gao (131516)

    Published 2024
    “…(B and D) The abundance of each metabolite was normalized to the mean value of the healthy groups and shown as log2. Significantly altered metabolites (B-H FDR < 0.1, log<sub>2</sub>(FC) > 1) are highlighted in blue (decreased) and red (increased), respectively. …”
  19. 3139

    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

    Published 2024
    “…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …”
  20. 3140

    Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

    Published 2024
    “…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …”